Lawmakers Begin Lobbying CMS Over Medicare Drug Formularies
This article was originally published in The Pink Sheet Daily
Executive Summary
Sen. Smith (R-Ore.) expresses concern about classification of antidepressants in U.S. Pharmacopeia's Medicare formulary guidelines during Senate Finance Committee hearing.